Final report of University Hospital Hradec Kralove to the clinical trial protocol no. SOV02

Abstract

Randomized, open-label, parallel group, multi-center Phase II clinical trial evaluating the effect of adding DCVAC/OvCa to standard chemotherapy in women with 1st relapsed of platinum-resistant epithelial ovarian cancer

Keywords

• DCVAC/OvCa
• ovarian cancer